Archrock, Inc. (AROC) Stock Price & How to Invest

Archrock, Inc. is a Houston-based energy infrastructure company that owns and operates a fleet of natural gas compressors, about 4.5 million operating horsepower at the end of June 2026, and rents them to producers and midstream operators under multi-year contracts. Compression is needed at almost every step of the gas value chain: at the wellhead, in gathering systems, at processing plants and along pipelines. Its Contract Operations segment (about $329 million of second-quarter 2026 revenue of ~$371 million, or roughly 89%) earns monthly fees based on horsepower deployed, with heavy exposure to the Permian Basin and an adjusted gross margin of about 71%. A smaller Aftermarket Services segment sells parts, maintenance and overhauls for customer-owned equipment. Acquisitions of TOPS (2024) and Natural Gas Compression Systems (2025) pushed the fleet further toward large, high-horsepower units.

Second-quarter 2026 results, reported August 4, were flat on earnings and down on revenue. Revenue slipped to ~$371.2 million from ~$383.2 million a year earlier because aftermarket revenue fell about 35% to ~$42 million on lower parts sales and weaker major maintenance demand, even as contract operations revenue grew about 3%. Adjusted EBITDA was ~$212.6 million, essentially unchanged, and diluted EPS was $0.38. Period-end utilization eased to 94.4% from 96.0%, and operating horsepower fell to ~4.5 million from ~4.7 million, partly because Archrock sold about 165,000 non-strategic horsepower. Management narrowed full-year adjusted EBITDA guidance to $865 to $885 million (from $865 to $915 million), citing make-ready and lube oil costs, softer aftermarket demand and incentive compensation, and said demand fundamentals had not changed.

The investment debate sits between contracted cash flow and near-term friction. On one side, leverage fell to ~2.6x from ~3.3x, the quarterly dividend rose about 10% to $0.23 with ~3.1x coverage, Archrock signed a long-term agreement covering about 665,000 horsepower with an existing customer, and it introduced $1.4 to $1.6 billion of growth capex guidance for 2027 through 2030. On the other, the guidance trim, lower utilization and a large capital program raised questions about margins and free cash flow. The shares fell from a 52-week high of ~$42.23 to about $29.50 by mid-October 2026, while all seven analysts in the latest rating tally rated the shares a buy or strong buy, with a mean price target near $42.

Archrock's demand ultimately depends on U.S. oil and gas activity, so a sustained drop in crude prices that slows Permian drilling, and with it associated gas growth, could delay new orders and pressure rates even though existing contracts keep running. The 2026 guidance trim showed that costs such as make-ready work, lube oil and incentive compensation can erode margins while revenue grows. Period-end utilization of 94.4%, down from 96.0%, leaves less room before idle horsepower starts to weigh on returns. Aftermarket Services is volatile: revenue fell about 35% in the second quarter on lower parts sales and maintenance work, and full-year guidance of $175 to $185 million is well below the prior-year pace. Competitors including Kodiak Gas Services and USA Compression Partners are also adding large-horsepower capacity, which could weaken pricing. Finally, the $1.4 to $1.6 billion growth capex plan for 2027 through 2030 competes with dividends, buybacks and debt reduction for cash, and customer concentration rises with large contracts like the ~665,000 horsepower agreement.

8 analysts publish price targets on AROC, averaging $42.38 against a $29.56 price as of October 2026, or +43.4%. The published targets run from $40.00 to $46.00, a narrow spread, and the ratings split 7 buy, 0 hold, 0 sell. Over the last six months there have been 5 raises and 3 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full AROC forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Archrock, Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. U.S. natural gas volume growth. LNG export capacity additions on the Gulf Coast, gas-fired generation for data centers and associated gas from Permian oil wells all require more compression to move molecules from the field to market. The most optimistic published target, $46.00, assumes this works close to its best case.

The case against. Archrock's demand ultimately depends on U.S. The most pessimistic target, $40.00, is roughly what AROC is worth if this bites instead.

Read the full bull and bear case on AROC, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Archrock, Inc.'s investor relations page or your broker.

• Q2 2026 revenue: ~$371.2 million (vs ~$383.2 million in Q2 2025)
• Q2 2026 adjusted EBITDA: ~$212.6 million (flat year over year)
• 2026 adjusted EBITDA guidance: $865 to $885 million (narrowed from $865 to $915 million)
• Market cap: ~$5.2 billion (share price ~$29.50)
• P/E (trailing / forward): ~16x / ~13.6x
• Dividend yield: ~3.1% ($0.23 quarterly, ~3.1x coverage)

At ~$5.2 billion of equity value plus roughly $2.35 billion of long-term debt (leverage ~2.6x), Archrock trades at about 8.5x the midpoint of its 2026 adjusted EBITDA guidance as of October 2026. That multiple is lower than when the shares sat near the 52-week high of ~$42.23 in June, reflecting the trimmed outlook, lower utilization and weaker aftermarket results. Second-quarter diluted EPS was $0.38, up from $0.36, and 2026 net income guidance is about $291 to $311 million. Third-quarter results, not yet scheduled by the company as of mid-October, will update these figures.

Other names that sit close to AROC: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get AROC exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so AROC sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where AROC fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Archrock is a high-margin, contracted compression business with a rising dividend and lower leverage, and as of October 2026 the market is weighing that against a trimmed 2026 outlook, weaker aftermarket demand and slightly lower utilization.

Whether AROC is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is AROC a buy or a sell?, and where the stock could go from here in the AROC stock forecast.

For income investors, whether AROC pays a dividend and how the payout looks is covered in does AROC pay a dividend? And to weigh AROC against a peer, read the full side-by-side comparisons: AROC vs KGS and AROC vs USAC.